Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
|Articles|December 1, 2020
- Vol 65 No 11
- Volume 65
- Issue 11
What did you think of the November cover story?
We want to hear from you.
Advertisement
Let Contemporary OB/GYN know what you thought of this month’s cover story, '
Do you agree that laparoscopic abdominal entry is the most dangerous part of any laparoscopic procedure?
Have you practiced shared decision-making with your patients? This peer-reviewed article, '
Let us know: Find us on Facebook and Twitter , or send an email to our editorial staff at COGEditorial@mmhgroup.com.
Read the full digital edition here .
Articles in this issue
almost 6 years ago
Cesarean delivery leads to unexpected outcomealmost 6 years ago
Desquamative inflammatory vaginitisalmost 6 years ago
Why shared decision-making matters more than everalmost 6 years ago
Advancing technology in diabetes managementalmost 6 years ago
The state of gynecologic robotic surgeryalmost 6 years ago
How much is my idea worth?almost 6 years ago
Innovating for improved patient outcomesalmost 6 years ago
Abdominal entry in laparoscopic surgeryalmost 6 years ago
Vaginal Dilators: A guide for health care professionalsAdvertisement
Related to this article
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Neurokinin receptor antagonists improve menopausal sleep disturbance
2
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
3
Brain fog at menopause: Separating normal change from dementia
4
Red flags that point beyond menopause in patients with night sweats
5